Vivesto AB (Vivesto AB) EBIT per Share : $-0.07 (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Vivesto AB EBIT per Share?

Vivesto AB's EBIT per Share for the three months ended in Dec. 2023 was $-0.04. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.07.

During the past 3 years, the average EBIT per Share Growth Rate was -50.30% per year. During the past 5 years, the average EBIT per Share Growth Rate was -2.80% per year. During the past 10 years, the average EBIT per Share Growth Rate was 11.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Vivesto AB's EBIT per Share or its related term are showing as below:

OASMY' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -79.1 Med: -1.2 Max: 54.7
Current: -50.3

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Vivesto AB was 54.70% per year. The lowest was -79.10% per year. And the median was -1.20% per year.

OASMY's 3-Year EBIT Growth Rate is ranked worse than
93.9% of 852 companies
in the Drug Manufacturers industry
Industry Median: 7.95 vs OASMY: -50.30

Vivesto AB's EBIT for the three months ended in Dec. 2023 was $-6.31 Mil.

Vivesto AB EBIT per Share Historical Data

The historical data trend for Vivesto AB's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivesto AB EBIT per Share Chart

Vivesto AB Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-0.12

-0.02

-0.09

-0.21

-0.07

Vivesto AB Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT per Share	Get a 7-Day Free Trial															-0.13	-0.01	-0.02	-0.01	-0.04

Vivesto AB EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Vivesto AB's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-12.551	/	179.348
=	-0.07

Vivesto AB's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-6.307	/	179.348
=	-0.04

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.07

Vivesto AB (OTCPK:OASMY) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Vivesto AB EBIT per Share Related Terms

Thank you for viewing the detailed overview of Vivesto AB's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Vivesto AB (Vivesto AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vivesto AB (OTCPK:OASMY) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

VIVE:Sweden OMAX:Germany

Address

Gustav III:s Boulevard 46, 5th Floor, Solna, SWE, SE-169 73

Website

https://www.vivesto.com

Vivesto AB is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company's product development leverages its proprietary technology platforms to manufacture novel drug formulations that are intended to demonstrate improved properties in comparison with current alternatives, which can lead to a reduced side-effect profile and an expanded therapeutic area. The company has a portfolio of projects targeting cancer treatments.